Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM. Bollineni VR, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e551-5. doi: 10.1016/j.ijrobp.2012.01.012. Epub 2012 Mar 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22417800
An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC).
Kerner GS, Bollineni VR, Hiltermann TJ, Sijtsema NM, Fischer A, Bongaerts AH, Pruim J, Groen HJ. Kerner GS, et al. Among authors: bollineni vr. EJNMMI Res. 2016 Dec;6(1):33. doi: 10.1186/s13550-016-0187-6. Epub 2016 Apr 18. EJNMMI Res. 2016. PMID: 27090118 Free PMC article.
Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.
Bruine de Bruin L, Bollineni VR, Wachters JE, Schuuring E, van Hemel BM, van der Wal JE, Slagter-Menkema L, de Bock GH, Steenbakkers RJ, Langendijk JA, Pruim J, van der Laan BF, Halmos GB. Bruine de Bruin L, et al. Among authors: bollineni vr. Radiother Oncol. 2015 Oct;117(1):106-12. doi: 10.1016/j.radonc.2015.07.012. Epub 2015 Aug 3. Radiother Oncol. 2015. PMID: 26250803
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Bollineni VR, Kerner GS, Pruim J, Steenbakkers RJ, Wiegman EM, Koole MJ, de Groot EH, Willemsen AT, Luurtsema G, Widder J, Groen HJ, Langendijk JA. Bollineni VR, et al. J Nucl Med. 2013 Aug;54(8):1175-80. doi: 10.2967/jnumed.112.115014. Epub 2013 Jun 10. J Nucl Med. 2013. PMID: 23753185
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR, Koole MJ, Pruim J, Brouwer CL, Wiegman EM, Groen HJ, Vlasman R, Halmos GB, Oosting SF, Langendijk JA, Widder J, Steenbakkers RJ. Bollineni VR, et al. Radiother Oncol. 2014 Nov;113(2):198-203. doi: 10.1016/j.radonc.2014.10.010. Epub 2014 Nov 27. Radiother Oncol. 2014. PMID: 25434768
High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature.
Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen HB, Haldorsen IS. Bollineni VR, et al. J Nucl Med. 2016 Jun;57(6):879-85. doi: 10.2967/jnumed.115.170597. Epub 2016 Jan 28. J Nucl Med. 2016. PMID: 26823564 Free article. Review.
Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy.
Bollineni VR, Wiegman EM, Pruim J, Groen HJ, Langendijk JA. Bollineni VR, et al. Cancer Treat Rev. 2012 Dec;38(8):1027-32. doi: 10.1016/j.ctrv.2012.04.003. Epub 2012 May 4. Cancer Treat Rev. 2012. PMID: 22560366 Review.
Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review.
Schelhaas S, Heinzmann K, Bollineni VR, Kramer GM, Liu Y, Waterton JC, Aboagye EO, Shields AF, Soloviev D, Jacobs AH. Schelhaas S, et al. Among authors: bollineni vr. Theranostics. 2017 Jan 1;7(1):40-50. doi: 10.7150/thno.16676. eCollection 2017. Theranostics. 2017. PMID: 28042315 Free PMC article. Review.
A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.
Bollineni VR, Kramer G, Liu Y, Melidis C, deSouza NM. Bollineni VR, et al. Cancer Treat Rev. 2015 Jun;41(6):496-502. doi: 10.1016/j.ctrv.2015.03.010. Epub 2015 Apr 11. Cancer Treat Rev. 2015. PMID: 25892290 Review.
13 results
Jump to page
Feedback